BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zhang CY, Liu S, Yang M. Treatment of liver fibrosis: Past, current, and future. World J Hepatol 2023; 15(6): 755-774 [PMID: 37397931 DOI: 10.4254/wjh.v15.i6.755]
URL: https://www.wjgnet.com/2150-5349/full/v15/i6/755.htm
Number Citing Articles
1
Girish L. Gupte, Anshu Srivastava. Chronic Liver Disease in Children: From Diagnosis to Liver TransplantationIndian Journal of Pediatrics 2024; 91(3): 260 doi: 10.1007/s12098-024-05030-3
2
Peng Ji, Yan Li, Zihan Wang, Siyu Jia, Xinyi Jiang, Hui Chen, Qun Wang. Advances in precision gene editing for liver fibrosis: From technology to therapeutic applicationsBiomedicine & Pharmacotherapy 2024; 177: 117003 doi: 10.1016/j.biopha.2024.117003
3
Arndt Vogel, Robert C. Grant, Tim Meyer, Gonzalo Sapisochin, Grainne M. O’Kane, Anna Saborowski. Adjuvant and neoadjuvant therapies for hepatocellular carcinomaHepatology 2023;  doi: 10.1097/HEP.0000000000000726
4
Ming Yang, Chun-Ye Zhang. Interleukins in liver disease treatmentWorld Journal of Hepatology 2024; 16(2): 140-145 doi: 10.4254/wjh.v16.i2.140
5
Sayed H. Seif el-Din, Olfat A. Hammam, Shahira M. Ezzat, Samira Saleh, Marwa M. Safar, Walaa H. El-Maadawy, Naglaa M. El-Lakkany. Hydroxysafflor yellow A protects against thioacetamide-induced liver fibrosis in rats via suppressing proinflammatory/fibrogenic mediators and promoting hepatic stellate cell senescence and apoptosisAsian Pacific Journal of Tropical Biomedicine 2023; 13(8): 348 doi: 10.4103/2221-1691.383689
6
Nidal Jaradat, Mohammed Hawash, Majid Sharifi-Rad, Ali Shakhshir, Shorooq Sobuh, Fatima Hussein, Linda Issa, Sondos Hamamrhe, Eman Al-Sheikh, Alaa Naser Ibrahim. Insights into free radicals scavenging, α-Amylase inhibition, cytotoxic and antifibrotic activities unveiled by Peganum harmala extractsBMC Complementary Medicine and Therapies 2024; 24(1) doi: 10.1186/s12906-024-04602-2
7
A. V. Vasyutin, V. V. Tsukanov, N. E. Veselova, E. G. Gorchilova, J. L. Tonkikh, A. A. Savchenko, A. G. Borisov. Association of neutropenia and decreased neutrophil function with liver fibrosis in patients with Opisthorchis felineus invasionMeditsinskiy sovet = Medical Council 2024; (15): 62 doi: 10.21518/ms2024-339
8
Tamer A. Addissouky, Majeed M. A. Ali, Ibrahim El Tantawy El Sayed, Yuliang Wang. Emerging advanced approaches for diagnosis and inhibition of liver fibrogenesisThe Egyptian Journal of Internal Medicine 2024; 36(1) doi: 10.1186/s43162-024-00283-y
9
Aneta Sokal-Dembowska, Sara Jarmakiewicz-Czaja, Katarzyna Ferenc, Rafał Filip. Can Nutraceuticals Support the Treatment of MASLD/MASH, and thus Affect the Process of Liver Fibrosis?International Journal of Molecular Sciences 2024; 25(10): 5238 doi: 10.3390/ijms25105238
10
Devadoss J. Samuvel, John J. Lemasters, C. James Chou, Zhi Zhong. LP340, a novel histone deacetylase inhibitor, decreases liver injury and fibrosis in mice: role of oxidative stress and microRNA-23aFrontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1386238
11
Watunyoo Buakaew, Sucheewin Krobthong, Yodying Yingchutrakul, Pachuen Potup, Yordhathai Thongsri, Krai Daowtak, Antonio Ferrante, Kanchana Usuwanthim. Investigating the Antifibrotic Effects of β-Citronellol on a TGF-β1-Stimulated LX-2 Hepatic Stellate Cell ModelBiomolecules 2024; 14(7): 800 doi: 10.3390/biom14070800
12
Man Na, Xingbiao Yang, Yongkun Deng, Zhaoheng Yin, Mingwei Li. Endoplasmic reticulum stress in the pathogenesis of alcoholic liver diseasePeerJ 2023; 11: e16398 doi: 10.7717/peerj.16398
13
Galit Weinstein, Yochai Schonmann, Hanny Yeshua, Shira Zelber‐Sagi. The association between liver fibrosis score and incident dementia: A nationwide retrospective cohort studyAlzheimer's & Dementia 2024; 20(8): 5385 doi: 10.1002/alz.14033
14
Sara T. Elazab, Walter H. Hsu. Ferulic acid ameliorates concanavalin A-induced hepatic fibrosis in mice via suppressing TGF-β/smad signalingToxicology and Applied Pharmacology 2024; 492: 117099 doi: 10.1016/j.taap.2024.117099
15
Simona Cernea. NAFLD Fibrosis Progression and Type 2 Diabetes: The Hepatic–Metabolic InterplayLife 2024; 14(2): 272 doi: 10.3390/life14020272
16
Mohammadjavad Sotoudeheian. Galectin-3 and Severity of Liver Fibrosis in Metabolic Dysfunction-Associated Fatty Liver DiseaseProtein & Peptide Letters 2024; 31(4): 290 doi: 10.2174/0109298665301698240404061300
17
Joey A. Muns, Erik Schooten, Rychon D. J. van Dasselaar, Yvet E. Noordman, Kevin Adamzek, Arthur C. Eibergen, Sebas D. Pronk, Sagel Cali, Niels J. Sijbrandi, Eugen Merkul, Sabrina Oliveira, Paul M.P. van Bergen en Henegouwen, R. Bart Takkenberg, Joanne Verheij, Stan F.J. van de Graaf, Bart A. Nijmeijer, Guus A.M.S. van Dongen. Preclinical targeting of liver fibrosis with a 89Zr-labeled Fibrobody® directed against platelet derived growth factor receptor-βEuropean Journal of Nuclear Medicine and Molecular Imaging 2024; 51(12): 3545 doi: 10.1007/s00259-024-06785-9
18
Pasquale Rapacciuolo, Claudia Finamore, Cristina Di Giorgio, Bianca Fiorillo, Carmen Massa, Ginevra Urbani, Silvia Marchianò, Martina Bordoni, Chiara Cassiano, Elva Morretta, Lucio Spinelli, Antonio Lupia, Federica Moraca, Michele Biagioli, Valentina Sepe, Maria Chiara Monti, Bruno Catalanotti, Stefano Fiorucci, Angela Zampella. Design, Synthesis, and Pharmacological Evaluation of Dual FXR-LIFR Modulators for the Treatment of Liver FibrosisJournal of Medicinal Chemistry 2024;  doi: 10.1021/acs.jmedchem.4c01651
19
Feng Chen, Qianhui Li, Xiaomin Xu, Fei Wang. Non-invasive Diagnostic Indicators and Antiviral Treatment Efficacy in CHB Patients with Different Liver Histopathological DegreesHepatitis Monthly 2024; 24(1) doi: 10.5812/hepatmon-147016
20
Wiebke‐Felicitas Nierath, Emily Leitner, Sabrina Reimann, Rico Schwarz, Burkhard Hinz, André Bleich, Brigitte Vollmar, Dietmar Zechner. GSK805 inhibits alpha‐smooth muscle expression and modulates liver inflammation without impairing the well‐being of miceThe FASEB Journal 2024; 38(16) doi: 10.1096/fj.202400733R
21
Daisuke Taguchi, Yohei Shirakami, Hiroyasu Sakai, Toshihide Maeda, Takao Miwa, Masaya Kubota, Kenji Imai, Takashi Ibuka, Masahito Shimizu. High-Fat Diet Delays Liver Fibrosis Recovery and Promotes Hepatocarcinogenesis in Rat Liver Cirrhosis ModelNutrients 2024; 16(15): 2506 doi: 10.3390/nu16152506
22
Xiao-Ling Wang, Meng Yang, Ying Wang. Roles of transforming growth factor-β signaling in liver diseaseWorld Journal of Hepatology 2024; 16(7): 973-979 doi: 10.4254/wjh.v16.i7.973
23
Shradha P Kakde, Maham Mushtaq, Maryyam Liaqat, Husnain Ali, Muhammad Muaz Mushtaq, Muhammad Asad Sarwer, Sami Ullah, Muhammad Wali Hassan, Asma Khalid, Syed Faqeer Hussain Bokhari. Emerging Therapies for Non-Alcoholic Steatohepatitis (NASH): A Comprehensive Review of Pharmacological and Non-Pharmacological ApproachesCureus 2024;  doi: 10.7759/cureus.69129
24
Vasudevan Sekar, Venkateish VP, Vani Vijay, Annapoorna BR, Nivya Vijayan, Madan Kumar Perumal. Inhibition of hepatic stellate cell activation by nutraceuticals: an emphasis on mechanisms of actionJournal of Food Science and Technology 2024; 61(11): 2046 doi: 10.1007/s13197-024-06002-3
25
Xiaoxin Liu, Ninglin Xia, Qinwei Yu, Ming Jin, Zifan Wang, Xue Fan, Wen Zhao, Anqin Li, Zhenzhou Jiang, Luyong Zhang. Silybin Meglumine Mitigates CCl4-Induced Liver Fibrosis and Bile Acid Metabolism AlterationsMetabolites 2024; 14(10): 556 doi: 10.3390/metabo14100556